The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce

FromBarron's Streetwise

Start listening View podcast show

The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce

FromBarron's Streetwise

ratings:

Length:

33 minutes

Released:

Dec 8, 2023

Format:

Podcast episode

Description

A top biotech analyst looks beyond Eli Lilly and Novo Nordisk for weight loss investments. Jack talks stocks, bonds, rates, and crypto.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Released:

Dec 8, 2023

Format:

Podcast episode

Titles in the series (100)

Get the lowdown on high finance each week with Barron’s columnist Jack Hough. Business leaders and trendspotters, insights and absurdities—this is Wall Street like you've never heard before.

Skip carousel

The Search for a Covid-19 Treatment by Barron's Streetwise
17 min listen
The Week Oil Got Weird by Barron's Streetwise
21 min listen
Private Equity For the Not-So-Rich by Barron's Streetwise
23 min listen
Chipotle's Back. Also, Who Needs REITs? by Barron's Streetwise
24 min listen
Are Stocks Melting Up? Plus, the Pet Economy Has Legs by Barron's Streetwise
24 min listen
TV's Sink Or Stream Moment by Barron's Streetwise
20 min listen
Coming soon: Barron's Streetwise by Barron's Streetwise
1 min listen
Time for Travel? Plus: Bowling's Back by Barron's Streetwise
21 min listen
Retail After the Pandemic by Barron's Streetwise
23 min listen
Disney after Coronavirus by Barron's Streetwise
21 min listen
Good News on Covid Treatments. And What's the Deal With Dave Portnoy? by Barron's Streetwise
19 min listen
Bitcoin v. Gold v. the Wobbling U.S. Dollar by Barron's Streetwise
25 min listen
Mohamed El-Erian on Stocks, Bitcoin, and Zombies by Barron's Streetwise
19 min listen
Are Home Buyers Heading to the Suburbs? by Barron's Streetwise
23 min listen
Vacation Edition: Jack Answers Listener Questions by Barron's Streetwise
15 min listen
Slack and Okta: Work-From-Home Winners by Barron's Streetwise
22 min listen
Are We MMT-ing Yet? by Barron's Streetwise
24 min listen
Smoke Break for Ethical Investors by Barron's Streetwise
23 min listen
Tik Tok and the Tech Titans by Barron's Streetwise
25 min listen
The Dean of Valuation Talks Tesla -- and College Tuition by Barron's Streetwise
25 min listen
Crisis Hits the Car Business, Again by Barron's Streetwise
21 min listen
Pizza and Hard Seltzer: The Quarantine Combo by Barron's Streetwise
20 min listen
Life of an Activist Short Seller by Barron's Streetwise
22 min listen
Bob Iger on Disney after Coronavirus (Rebroadcast) by Barron's Streetwise
21 min listen
Reed Hastings on Netflix's Secret Sauce by Barron's Streetwise
27 min listen
An Election Dispute Could Rattle Stocks. Plus, The Future of Movies by Barron's Streetwise
25 min listen
Paintings For Profits: Should Investors Buy Shares of Art? by Barron's Streetwise
24 min listen
Biotech, Solar, and Hot Dogs--Listener Questions Answered by Barron's Streetwise
22 min listen
Bitcoin, Dividends, Tech Overload--Listener Questions by Barron's Streetwise
15 min listen
Mark Cuban on Sports and TV. Plus, 5G iPhone Stuff by Barron's Streetwise
22 min listen

More Episodes from Barron's Streetwise

Skip carousel

Why Starbucks Went Cold. Plus, Apple’s A.I. Opportunity. by Barron's Streetwise
31 min listen
Chip Stocks and the A.I. Explosion by Barron's Streetwise
33 min listen
The Problem With Covered Call Writing by Barron's Streetwise
28 min listen
Fuzzy Panda Attacks Globe Life by Barron's Streetwise
33 min listen
Supervoting Shares and Bond Barbells by Barron's Streetwise
29 min listen
Underpants Armageddon by Barron's Streetwise
25 min listen
Toyota Stock is Trouncing Tesla. Really. by Barron's Streetwise
33 min listen
STRIPS Strategy for Safe Money. Plus, Big Small Caps and Bear Talk by Barron's Streetwise
32 min listen
The Bull Case for AT&T by Barron's Streetwise
33 min listen
The $600,000 Case for Bitcoin by Barron's Streetwise
33 min listen
Bonds—Ladder or Fund? TIPS or Nah? by Barron's Streetwise
29 min listen
On Financial Nudism by Barron's Streetwise
31 min listen
Nvidia's Make-Or-Break Earnings Report by Barron's Streetwise
26 min listen
Is Uranium Too Hot? Plus, TV's Sporty Consortium by Barron's Streetwise
32 min listen
Paramount Eyes An Offer. Plus, What’s Ailing CVS? by Barron's Streetwise
30 min listen
Oil Outlook, and an Exxon Upgrade by Barron's Streetwise
30 min listen
Disney, Harley, Whopper, Whopper by Barron's Streetwise
34 min listen
Airline Stocks, Bitcoin ETFs, Babies by Barron's Streetwise
33 min listen
Should You Pay Off the Mortgage Early? by Barron's Streetwise
27 min listen
Bary’s Top 10 Stocks for 2024 by Barron's Streetwise
31 min listen
Bonds, Solar, and Cheese Balls by Barron's Streetwise
28 min listen
Intel and Amazon by Barron's Streetwise
30 min listen
3 Small Cap Picks. Plus, Balancing the Magnificent 7 by Barron's Streetwise
30 min listen
Tractor Talk With CNH CEO Scott Wine by Barron's Streetwise
33 min listen
Ebitda vs. Ugly. Plus, TIPS, QQQ ads, and the Innie Yield Curve by Barron's Streetwise
32 min listen
3 European Blue Chips Below 6 Times Earnings. Plus, Free Toys by Barron's Streetwise
33 min listen
The Investing Merits of the High-Deductible Health Plan by Barron's Streetwise
29 min listen
Don’t Lick That Frog—the Pull and Peril of a 17% Yield by Barron's Streetwise
31 min listen
Picking Value Stocks. Plus, Magnificent 7 Price Check by Barron's Streetwise
37 min listen
Looking for Deals in Rundown REITs by Barron's Streetwise
31 min listen

Related podcast episodes

Skip carousel

Building Roblox’s $30 Billion Biz; Antibody Treatments with Dr. Scott Gottlieb: Eli Lilly says its Covid-19 antibody therapy reduced the risk of hospitalization and death by 87% in a study of more than 750 high-risk coronavirus patients. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, discusses the news from Lilly and the difficulties around distributing Covid antibody drugs. Kids online gaming company Roblox (RBLX) is going public today through a direct listing on the New York Stock Exchange. Roblox CEO, David Baszucki, discusses the listing, user growth, the path to profitability and why Roblox is so unique. Plus, Tesla’s on a wild ride and inflation has captured investor focus. by Squawk Pod
36 min listen
Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma by Beyond Biotech - the podcast from Labiotech
46 min listen
Ep. 94: OppFi CEO Jared Kaplan, MiMedx, Leslie’s, Cadiz: OppFi CEO Jared Kaplan (OPFI) says his subprime lender is better than a payday lender, even with annual interest rates above 100%. Controversial biotech MiMedx Group (MDXG) suffers after a pair of failed clinical trials. Pool supply retailer Leslie's (LE... by The Drill Down
42 min listen
10-12-20: What Is Driving The Historic Demand For Life Sciences REITs? by InvestTalk
45 min listen
5 Big Reveals from the 2022 JP Morgan Healthcare Conference by The 7investing Podcast
24 min listen
Ep. 76: Jay Jacobs: These High-Growth ETF Themes Have Seen Double-Digit Returns In Coronavirus Rally: Using thematic investing to maximize profits. by Investing With IBD
49 min listen
Ep. 113: Open Lending with Villere portfolio manager Lamar Villere, ChemoCentryx, Allogene Therapeutics, Opendoor Technologies, Facebook by The Drill Down
33 min listen
Coronavirus Hopes, Big Bets on Biotech, and Jordan Rules.: Markets rallying on promising vaccine news and reassuring words from Federal Reserve Chairman Jay Powell. We’ll talk about what it means for your investments. Plus, investors -big and small-are flocking into the biotech sector in large numbers. We’ll look at the names they’re flowing into and whether you should follow suit. And, if Michael Jordan were a stock, analysts would have a buy rating on the former basketball icon. We will tell you why. by The Exchange
41 min listen
Money Talks: Why weight-loss drugs will reshape the world: Our podcast on markets, the economy and business. This week, it’s not just waistlines that could see the benefit from the new “miracle” drugs by Money Talks from The Economist
37 min listen
Money Talks: Why weight-loss drugs will reshape the world: Our podcast on markets, the economy and business. This week, it’s not just waistlines that could see the benefit from the new “miracle” drugs by Economist Podcasts
37 min listen
The Investment Hour: Living in a bubble: Bubbles are both an exciting and terrifying part of market life, offering investors the potential for both huge gains and also massive losses. But how do investors navigate a phenomenon they often don't know they're experiencing unti... by Investors' Chronicle
59 min listen
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD by Business Of Biotech
54 min listen
The Meteoric Rise of Liquid Staking (and Why You Should Care) w/ Jacob Blish: Liquid staking is now the biggest DeFi sector but there are challenges ahead, especially in the U.S. by Raoul Pal: The Journey Man
34 min listen
15- The Reason Mutual Funds Aren't Mutual: You have different options when it comes to inves… by InvestED: The Rule #1 Investing Podcast
41 min listen
The Legendary Steve Gorlin's Golden Rules by Business Of Biotech
58 min listen
Sunday, July 5, 2015 by 60 Minutes
43 min listen
Ep. 214: Li-Cycle CEO Ajay Kochhar, Recursion Pharmaceuticals, Constellation Brands, Paychex by The Drill Down
48 min listen
6 Companies, 4 Strong Balance Sheets: What separates a strong balance sheet from a weak one? Motley Fool senior analysts John Rotonti and Bill Mann discuss: - Assets, liabilities, and when more liabilities can actually be a good thing - A surprising way one retailer generates cash from... by Motley Fool Money
26 min listen
Creating Synergies Between Portfolio Companies, with Yaacov Michlin, BioLight by OIS Podcast | Ophthalmology's leading Podcast
40 min listen
Surveillance: Recovery Risks With Rogoff by Bloomberg Surveillance
26 min listen
This ETF is Rated R by Trillions
31 min listen
Beyond Biotech podcast 8: Biotech Growth Trust, Deep Science Ventures, Endogena Therapeutics, eureKARE by Beyond Biotech - the podcast from Labiotech
61 min listen
#50 - Jay Jacobs - Lithium, Clean Tech, Genomics & the Benefits of Investing in Themes by Opto Sessions – Invest in the Next Big Idea
53 min listen
Future of Drug Discovery: Generative AI in Pharma and Medicine: #ai #generativeai #drugdiscovery #pharma In this episode of CXOTalk, we have the pleasure of speaking with Dr. Alex Zhavoronkov, the founder and CEO of Insilico Medicine. Insilico Medicine uses artificial intelligence to enhance drug discovery. By... by CXOTalk
51 min listen
How WMG Takes on Retail Development Challenges - Where We Buy #224: WMG Development has its roots in 2003, assisting in the development of real estate for Heartland Dental. Today, while WMG still develops projects with Heartland as a tenant, it now has a portfolio of nearly 400 properties in 35 states. Craig... by Where We Buy: Retail Real Estate with James Cook
21 min listen
Just Keep Buying by Trillions
35 min listen
01-28-20: Opinion: 12 Deadly Sins To Avoid When Saving For Retirement: To improve your investment results, eliminate serious financial transgressions like negligence and imprudence. Today's Stocks & Topics: Global Real Estate, Fed Meeting, A Million Dollars, XOM - Exxon Mobil Corp., Coronavirus, 401k, SBGL -... by InvestTalk
47 min listen
Why The Rise of Passive Investing Might Be Distorting The Market by Odd Lots
45 min listen
UPCOMING SPECIAL: Unraveling Biotech's Legal Enigmas With Keir LoIacono by Business Of Biotech
2 min listen
Ep. 155: VICI Properties CEO Ed Pitionak, Beyond Meat, Roblox, Polaris by The Drill Down
40 min listen

Discover this podcast and so much more

The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce

The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce

Description

Titles in the series (100)

More Episodes from Barron's Streetwise

Related podcast episodes